SARSYS AB reported a challenging 2024 with declining sales, negative equity, and a subsidiary in restructuring, but enters 2025 with a strong order backlog and ongoing capital measures. Material uncertainty remains regarding continued operations.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.